Concepedia

Chengfang Lv

CL

9

Publications

384

Citations

9

H-Index

2009

Active since

Affiliations

Harbin Medical University(Current)

First Affiliated Hospital of Harbin Medical University

Fourth Affiliated Hospital of Harbin Medical University

Chengfang Lv is an author at Harbin Medical University specializing in medicine, cell biology, and pulmonary vascular disease.

ORCID

Top concepts

Publications per year

2009–2021

9

Publications

9

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia

Jin Zhou, Yingmei Zhang, Xiaoxia Li et al. · Blood · 2009 · 115 citations · Full text

Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration

Chengfang Lv, Lili Sun, Zhibo Guo et al. · Journal of Translational Medicine · 2018 · 60 citations · Full text

Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia

Yingmei Zhang, Zhuo Zhang, Jinmei Li et al. · Cancer · 2012 · 48 citations · Full text

Platelet-Derived Growth Factor-B (PDGF-B) Induced by Hypoxia Promotes the Survival of Pulmonary Arterial Endothelial Cells through the PI3K/Akt/Stat3 Pathway

Limin Li, Mengyuan Xu, Xiaoxia Li et al. · Cellular Physiology and Biochemistry · 2015 · 46 citations · Full text

Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL

Linlin Zhao, Chengfang Lv, Lili Sun et al. · Investigational New Drugs · 2021 · 39 citations

Rows per page

1–5 of 9